Arma: Prostate cancer (PC) is driven by androgen receptor (AR), and is the second leading cause of cancer in men in the US. AR-V7 (AR splice variant) is a major driver of resistance in PC. We are developing compounds to inhibit AR-V7.
Paraskevi Giannakakou, PhD, Professor, WCM; Cherie Au, PhD, Postdoc, WCM; Eiman Mukhtar, PhD, Postdoc, WCM
CapCell Biologics: Implants to deliver biologics using licensed NASA cell encapsulation technology.
Benjamin Young, CEO; Jon Zaikowski, President
Ossis Therapeutics: Developing methods to modulate bone formation.
Matthew Greenblatt, Assistant Professor, WCM; Barzan Sadiq, PhD, Postdoc, WCM
OpenCellAI: Software pathology and diagnostics that automates clinical imaging.
Henri Berger, PhD Student, WCM
Patient Activated Learning System: Web-based resource for unbiased, physician-authored, evidence-based, engaging, and easily understood health-related information.
Monika Safford, MD, Chief of Internal Medicine, WCM; Steve Cohen, CFP, CPA/PFS; Elizabeth Baquero, Research Program Manager, WCM
STORK.ai: Developing a unique patent-pending software using an artificial intelligence approach to reliably assess embryo quality.
Iman Hajirasouliha, PhD, Assistant Professor, WCM; Olivier Elemento, PhD, Professor, WCM; Sam Tischfield, PhD, Research Fellow, MSKCC
XRG: Augmented reality-based image guidance system that uses machine learning to provide automated registration of anatomic digital models segmented from CT scans to catheter positions segmented from fluoroscopy.
Bobak Mosadegh, PhD, Assistant Professor, WCM
Michael Aberman, MD, MBA, Adjunct Partner, IndieBio
Stephen Chambers, PhD, Partner, IndieBio
Pascal Krotee, PhD, Investment Associate, Kairos Ventures
Jonathan Mandelbaum, PhD, Senior Associate, OrbiMed
Andrew Schiff, MD, Managing Partner, Aisling Capital
Whitney Snider, MD, MBA, Head of Alexandria LaunchLabs - NYC; Principal, Alexandria Venture Investments
Robert Spiegel, MD, FACP, Former CMO, Schering Plough